Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms

Journal of Neurochemistry

Volumn 86, Issue 3, 2003, Pages 582-590

  Andorfer, Cathy ^a   Kress, Yvonne ^a   Espinoza, Marisol ^a   De Silva, Rohan ^b   Tucker, Kerry L ^c   Barde, Yves Alain ^c   Duff, Karen ^d   Davies, Peter ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Aggregation; Alzheimer's disease; Non mutant tau; Phosphorylation; Transgenic

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

AGE FACTORS; ALTERNATIVE SPLICING; ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN CHEMISTRY; DENDRITES; DISEASE MODELS, ANIMAL; HUMANS; MACROMOLECULAR SUBSTANCES; MICE; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; NEURONS; PHOSPHORYLATION; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAU PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 0041803006     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01879.x     Document Type: Article

References (43)

1. Andorfer C. A. and Davies P. (2000) PKA phosphorylations on tau: developmental studies in the mouse. Dev. Neurosci. 22, 303-309.
2. Buee L. and Delacourte A. (1999) Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol. 9, 681-693.
3. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A. and Hof P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95-130.
4. Dayanandan R., Van Slegtenhorst M., Mack T. G., Ko L., Yen S. H., Leroy K., Brion J. P., Anderton B. H., Hutton M. and Lovestone S. (1999) Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett. 446, 228-232.
5. Duff K., Knight H., Refolo L. M., Sanders S. Yu X., Picciano M., Malester B., Hutton M., Adamson J., Goedert M., Burki K. and Davies P. (2000) Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol. Dis. 7, 87-98.
6. Goedert M., Spillantini M. G., Jakes R., Rutherford D. and Crowther R. A. (1989a) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526.
7. Goedert M., Spillantini M. G., Potier M. C., Ulrich J. and Crowther R. A. (1989b) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8, 393-399.
8. Goode B. L., Chau M., Denis P. E. and Feinstein S. C. (2000) Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenetative disease. J. Biol. Chem. 275, 38182-38189.
9. Gotz J. (2001) Tau and transgenic animal models. Brain Res. Brain Res. Rev. 35, 266-286.
10. Gotz J., Chen F., van Dorpe J. and Nitsch R. M. (2001) Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Aβ 42 fibrils. Science 293, 1491-1495.
11. Greenberg S. G. and Davies P. (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl Acad. Sci. USA 87, 5827-5831.
12. Greenberg S. G., Davies P., Schein J. D. and Binder L. I. (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267, 564-569.
13. Hardy J. A. and Higgins G. A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
14. Hasegawa M., Smith M. J. and Goedert M. (1998) Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett. 437, 207-210.
15. Hong M., Zhukareva V., Vogelsberg-Ragaglia V., Wszolek Z., Reed L., Miller B. I., Geschwind D. H., Bird T. D., McKeel D., Goate A., Morris J. C., Wilhelmsen K. C., Schellenberg G. D., Trojanowski J. Q. and Lee V. M. (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282, 1914-1917.
16. Hutton M., Lendon C. L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R. C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J. M., Nowotny P., Heutink P. et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
17. Ishihara T., Hong M., Zhang B., Nakagawa Y., Lee M. K., Trojanowski J. Q. and Lee V. M. (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24, 751-762.
18. Ishizawa K., Ksiezak-Reding H., Davies P., Delacourte A., Tiseo P., Yen S. H. and Dickson D. W. (2000) A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease. Acta Neuropathol. 100, 235-244.
19. Jackson G. R., Wiedau-Pazos M., Sang T. K., Wagle N., Brown C. A., Massachi S. and Geschwind D. H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509-519.
20. Jicha G. A., Bowser R., Kazam I. G. and Davies P. (1997a) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 48, 128-132.
21. Jicha G. A., Lane E., Vincent I., Otvos L. Jr, Hoffmann R. and Davies P. (1997b) A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J. Neurochem. 69, 2087-2095.
22. Jicha G. A., Berenfeld B. and Davies P. (1999a) Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. J. Neurosci. Res. 55, 713-723.
23. Jicha G. A., Weaver C., Lane E., Vianna C., Kress Y., Rockwood J. and Davies P. (1999b) cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J. Neurosci. 19, 7486-7494.
24. Kosik K. (1989) Developmentally regulated expression of specific tau sequences. Neuron 2, 1389-1397.
25. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Van Slegtenhorst M., Gwinn-Hardy K., Paul Murphy M., Baker M. YuX., Duff K., Hardy J., Corral A., Lin W. L., Yen S. H., Dickson D. W., Davies P. and Hutton M. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405.
26. Lewis J., Dickson D. W., Lin W. L., Chisholm L., Corral A., Jones G., Yen S. H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M. and McGowan E. (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491.
27. Miyasaka T., Morishima-Kawashima M., Ravid R., Kamphorst W., Nagashima K. and Ihara Y. (2001) Selective deposition of mutant tau in the FTDP-17 brain affected by the P301L mutation. J. Neuropathol. Exp. Neurol. 60, 872-884.
28. Otvos L. Jr, Feiner L., Lang E., Szendrei G. I., Goedert M. and Lee V. M. (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J. Neurosci. Res. 39, 669-673.
29. Poorkaj P., Kas A., D'Souza I., Zhou Y., Pham Q., Stone M., Olson M. V. and Schellenberg G. D. (2001) A genomic sequence analysis of the mouse and human microtubule-associated protein tau. Mamm. Genome 12, 700-712.
30. Rasool C. G., Svendsen C. N. and Selkoe D. J. (1986) Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease. Ann. Neurol. 20, 482-488.
31. Rogers J. D., Brogan D. and Mirra S. S. (1985) The nucleaus basalis of Meynert in neurological disease: a quantitative morhphological study. Ann. Neurol. 17, 163-170.
32. Saper C. B., German D. C., White C. L. and 3rd (1985) Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: possible role in cell loss. Neurology 35, 1089-1095.
33. de Silva R., Lashley T., Strand G., Gibb G., Hanger D., Hope A., Reid A., Bandopadhyay R., Utton M., Strand C., Jowett T., Khan N., Anderton B., Wood N., Holton J., Revesz T. and Lees A. (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with 3 or 4 microtubule binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathology and Applied Neurobiology 29, 288-302.
34. Spillantini M. G., Murrell J. R., Goedert M., Farlow M. R., Klug A. and Ghetti B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA 95, 7737-7741.
35. Tagliavani F. and Pilleri G. (1983) Basal nucleus of Meynert: a neuropathological study in Alzheimer's disease, simple senile dementis, Pick's disease and Huntington's chorea. J. Neurol. Sci. 62, 243-260.
36. Taylor J. P., Hardy J. and Fischbeck K. H. (2002) Toxic proteins in neurodegenerative disease. Science 296, 1991-1995.
37. Togo T., Sahara N., Yen S. H., Cookson N., Ishizawa T., Hutton M., de Silva R., Lees A. and Dickson D. W. (2002) Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J. Neuropathol. Exp. Neurol. 61, 547-556.
38. Tucker K. L., Meyer M. and Barde Y. A. (2001) Neurotrophins are required for nerve growth during development. Nat. Neurosci. 4, 29-37.
39. Uboga N. V. and Price J. L. (2000) Formation of diffuse and fibrillar tangles in aging and early Alzheimer's disease. Neurobiol. Aging 21, 1-10.
40. Utton M. A., Gibb G. M., Burdett I. D. J., Anderton B. H. and Vandecandelaere A. (2001) Functional differences of tau isoforms containing 3 or 4 C-terminal repeat regions and the influence of oxidative stress. J. Biol. Chem. 276, 34288-34297.
41. Weaver C. L., Espinoza M., Kress Y. and Davies P. (2000) Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol. Aging 21, 719-727.
42. Whitehouse P. J., Struble R. G., Clark A. W. and Price D. (1982) Alzheimer's disease: plaques, tangles and the basal forebrain. Ann. Neurol. 12, 494.
43. Wong P. C., Cai H., Borchelt D. R. and Price D. L. (2001) Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics. J. Mol. Neurosci. 17, 233-257.